Navigation Links
Upcoming Webinar Hosted by Xtalks to Examine the Latest eClinical Suite and How to Take Advantage While Avoiding Vendor Lock-Ins in Clinical Trials
Date:1/11/2019

Drawing on over 22 years of software development expertise, the live webinar taking place on Tuesday, January 22, 2019 at 2:30pm EST will explore some of the key lessons that have driven customer satisfaction with their eClinical suite. Explore the risks and benefits of using one vendor vs. using multiple vendors, and find out how to ensure that you continue to be able to take advantage of the latest technology long after you’ve made your choice in order to decrease your risk and keep you competitive—all while staying clear of vendor lock-ins.

Not all eClinical applications are the same. For one thing, an eTMF, an EDC, and a CTMS all fulfill different functions. Perhaps more importantly, they are all built with varying degrees of sophistication.

The eTMF and EDC are both relatively simple applications in the IT world. Either can be introduced for a specific study or for a number of studies. If you’re unhappy with your eTMF or EDC applications, you can switch without too much fuss.

The CTMS, on the other hand, is highly sophisticated. It is the nerve center of the eClinical suite and is highly integrated with other software. It can be expensive to introduce, and its normal lifespan is more than 13 years.

Therefore, once you install a CTMS, you will be committed for well over a decade. That’s why it is so important to choose your CTMS carefully, and be armed with the best knowledge in order to do so.

The presentation will discuss:

  •     Where innovation is typically born, and how it eventually gets to the end user
  •     What drives innovation, and what stifles it
  •     A high-level overview of how an eClinical suite functions
  •     Key factors for optimal software integration
  •     How to ensure your organization is poised to be able to adopt new technology
  •     The steady diet of myths and other tall tales the software industry feeds us
  •     Negotiation tips to avoid “vendor lock-in” and how to avoid common contract traps

Join BSI’s expert speakers Jens B. Thuesen, BSI CTMS Business Development & Chairman of the Board of Directors and Pamela Penman, CTMS Business Development, as they dive into what really matters when choosing a CTMS to complete your eClinical suite, and gain the knowledge and tools to make a better decision for your organization.

For more information about this complimentary webinar visit: Assembling the eClinical Suite: Taking Advantage of the Latest Technology While Avoiding Vendor Lock-Ins.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Read the full story at https://www.prweb.com/releases/upcoming_webinar_hosted_by_xtalks_to_examine_the_latest_eclinical_suite_and_how_to_take_advantage_while_avoiding_vendor_lock_ins_in_clinical_trials/prweb16027565.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. ComplianceOnline’s Upcoming Seminars by Ex-FDA Officials
2. Agenus to Participate at Two Upcoming Immuno-Oncology Conferences
3. Agilent Technologies Discusses New Approach to Thyroid Hormone Analysis in Upcoming Webinar
4. Catalent Executives to Present on Clinical Trial Supply Management and Optimizing Product Development at Upcoming BioPharma Asia Conference
5. Cellecta, Inc. Announces Upcoming Presentations at the American Association for Cancer Research 2017 Annual Meeting
6. Astute Medical, Inc. Previews Scientific Presentations At Upcoming International Nephrology Conference
7. An upcoming segment of the Rob Lowe-Hosted "Informed" Public Television Series will Discuss Climate Change
8. Upcoming MichBio BioMixer on 2/23/17, Hosted by MichBio & Avomeen
9. Symic Bio to Present at Upcoming Conferences
10. FDASmart Inc.’s Breach of Contract Lawsuit Against Dishman USA Survives Appeal, India-based Dishman’s New Jersey Subsidiary Legally Bound in Upcoming Trial by Jury
11. Discover the Clinical Significance of 1,25-Dihydroxyvitamin D Testing in Upcoming DiaSorin Webinar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/19/2019)... ... March 19, 2019 , ... ... Minolta) today announced the formation of their inaugural Scientific Advisory Board. ... medicine that takes into account individual variability in genes, environment, and lifestyle to ...
(Date:3/15/2019)... ATLANTA (PRWEB) , ... March ... ... acquisition of 100% equity in American Process Inc. and affiliate companies including ... Alpena Biorefinery in Alpena Michigan, the Thomaston Biorefinery and R&D center in ...
(Date:3/14/2019)... ... 2019 , ... Murrieta Genomics , the genomic sequencing business incubator, has ... business experience to bear as genomic sequencing startups build their business models. , “We ... that our Advisory Board brings to the table. Many of these experts would be ...
(Date:3/11/2019)... ... ... In this live webinar, the featured speakers will focus on the many attributes ... learn how to use the information they have from the protocol and clinical trial ... scheme is properly designed and set up to ensure flawless execution. As clinical trial ...
Breaking Biology Technology:
(Date:2/22/2019)... RIVER FALLS, Wisc. (PRWEB) , ... February 21, 2019 , ... ... fast-growing movement is now expected when creating natural foods and beverages. It is quite ... reading the fine print. Yet, meat products are not immune to this label scrutiny. ...
(Date:2/22/2019)... (PRWEB) , ... February 21, 2019 , ... ... Diagnostics (Fuzionaire Dx) have executed a research agreement establishing a collaborative program to ... effort will be to develop new radiopharmaceutical lead candidates and will explore Fuzionaire ...
(Date:2/19/2019)... ... February 18, 2019 , ... ... delivery technologies and development solutions for drugs, biologics and consumer health products, ... highest external business partner recognition, the External Business Partner of the Year ...
Breaking Biology News(10 mins):